Join GPEI colleagues for a webinar to learn more about next steps for novel oral polio vaccine type 2 (nOPV2) rollout. Presenters will discuss topics including safety, genetic stability and clinical data to date, latest SAGE developments regarding nOPV2 use, use requirements going forward, and supply and prioritization. The presentation will be followed by a live Q&A session.
This webinar will be for internal GPEI audiences, and will be available live in English, Arabic and French. GPEI regional teams are encouraged to invite country-level staff as appropriate.
If you have any questions about the webinar or experience any technical difficulties during the event, please reach out to Zulaa Sainjargal ([email protected]) or Samantha Ritter ([email protected]) or Emily Wright ([email protected]).